CIK 0001501989
- Accelerated filer
CytomX Therapeutics, Inc.
Sign in to watch- Ticker
- CTMX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 273521219
- Phone
- +1 650-515-3185
- Business address
- 151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-18 | ROWLAND LLOYD A General Counsel | Sale | −10,203 | $0.60 | $6K | 120,594 |
| 2024-08-20 | ROWLAND LLOYD A General Counsel | Exercise or conversion | +11,250 | 134,978 | ||
| 2024-08-20 | ROWLAND LLOYD A General Counsel | Sale | −4,181 | $1.23 | $5K | 130,797 |
| 2024-08-20 | ROWLAND LLOYD A General Counsel | Exercise or conversion · Performance Stock Units (PSUs) | −11,250 | 0 | ||
| 2024-03-19 | ROWLAND LLOYD A General Counsel | Sale | −5,268 | $2.09 | $11K | 117,728 |
| 2024-01-18 | ROWLAND LLOYD A General Counsel | Grant or award | +25,000 | 122,996 | ||
| 2024-01-18 | ROWLAND LLOYD A General Counsel | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2024-01-18 | ROWLAND LLOYD A General Counsel | Grant or award · Performance Stock Units (PSUs) | +75,000 | 75,000 | ||
| 2023-12-20 | ROWLAND LLOYD A General Counsel | Sale | −4,077 | $1.38 | $6K | 97,996 |
| 2023-12-17 | ROWLAND LLOYD A General Counsel | Exercise or conversion | +11,250 | 102,073 | ||
| 2023-12-17 | ROWLAND LLOYD A General Counsel | Exercise or conversion · Performance Stock Units (PSUs) | −11,250 | 11,250 | ||
| 2023-09-22 | ROWLAND LLOYD A General Counsel | Sale | −5,486 | $1.30 | $7K | 80,609 |
| 2023-09-20 | ROWLAND LLOYD A General Counsel | Grant or award | +15,000 | 86,095 | ||
| 2023-03-16 | ROWLAND LLOYD A General Counsel | Sale | −2,037 | $1.98 | $4K | 71,095 |
| 2023-02-02 | ROWLAND LLOYD A General Counsel | Grant or award | +25,000 | 73,132 | ||
| 2023-02-02 | ROWLAND LLOYD A General Counsel | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2023-02-02 | ROWLAND LLOYD A General Counsel | Grant or award · Performance Stock Units (PSUs) | +75,000 | 75,000 | ||
| 2022-08-10 | ROWLAND LLOYD A General Counsel | Grant or award · Stock Option (Right to Buy) | +135,000 | 135,000 | ||
| 2022-08-10 | ROWLAND LLOYD A General Counsel | Grant or award · Performance Stock Units (PSUs) | +22,500 | 22,500 | ||
| 2022-07-20 | ROWLAND LLOYD A General Counsel | Sale | −5,602 | $1.42 | $8K | 43,689 |
Page 1 of 2 · 31 trades